-
-
-
-
-
-
-
Oral Wegovy reaches 33% of total prescriptions by May
-
-
-
-
-
-
-
Hims and Hers (HIMS) PT Lowered to $25 at BofA Securities
-
-
-
-
-
-
-
Hims & Hers stock tumbles as revenue, EBITDA miss estimates
-
-
-
-
-
-
-
Hims and Hers (HIMS) PT Raised to $32 at Canaccord
-
-
-
-
-
-
-
Amazon Pharmacy adds same-day delivery for Ozempic pill
-
-
-
-
-
-
-
FDA encourages testosterone therapy makers to seek low libido indication
-
-
-
-
-
-
-
Canaccord on Hims and Hers (HIMS): 'Novo partnership goes live; near-term headwind to revenue, long-term tailwind to the story'
-
432,376 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

